Trial NCT01913015

View at ClinicalTrials.gov 
Org. Study IDs: 9130
Secondary IDs: NCI-2013-01223 P30CA069533

Last trial update was posted on 2017-04-28

MeSH Interventions

Abiraterone Acetate

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Stopping Reasons

After enrollment of the first 3 subjects, an interim assessment was conducted. Comparing DBS sampling to plasma PK levels yielded unconvincing results.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID